返回 Agenda
[Session 4] Cardiovascular Safety in Oncology Drug Development: Mechanisms of Cardiotoxicity
Session Chair(s)
Katsuyoshi Chiba, PhD
Senior Director and Head, Group III, Medicinal Safety Research Laboratories, R&D
Daiichi Sankyo Co., Ltd., Japan
Atsushi Sugiyama, MD, PhD
Professor and Chairman, Department of Pharmacology
Toho University Faculty of Medicine, Japan
Speaker(s)
Drug-Induced Cardiac Toxicity: Translating Non-Clinical Observations into Early Clinical Investigation
Atsuhiko T. Naito, MD, PhD
Toho University Faculty of Medicine, Japan
Associate Professor, Department of Pharmacology, School of Medicine
Development and Standardization of in vitro Contractility Method Using Human iPS Cell-Derived Cardiomyocytes
Yasunari Kanda, PhD
National Institute of Health Sciences, Japan
Head of Division of Pharmacology
Molecular Pathways and Pathophysiology of TKI Induced Cardiotoxicity
Junichi Ishida, MD, PhD
The University of Tokyo Hospital, Japan